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Despite the presence of the strongest T-cell epitope of gp120, which is active in vitro (3-7) and an exposed B-cell epitope (8, 9) , the C-terminus of the C2 region encompassing amino acids 280-306 is not immunogenic in humans (3, (10) (11) (12) . Absence of the active B-cell epitope within this peptide indicates that antibodies in sera of HIV patients recognizing this region of HIV-1 gp120 represent autoreactive antibodies elicited by some human antigen. Vasoactive intestinal peptide (VIP) was identified as the human antigen likely inducing these natural antibodies, which are crossreactive with peptide RSANFTDNAKTIIVQLNQSVEIN (denoted as peptide NTM) derived from the C2 region of HIV-1 gp120 (13, 14) .
One might conclude from these previous data that this conserved area of HIV-1 gp120 cannot be used as a vaccine component because the human immune system is unresponsive, or tolerant, to epitope(s) within this part of the molecule. In order to overcome this problem in the development of a possible vaccine, it would be necessary to design antigens which are crossreactive with the C-terminus of the C2 region and, which can escape the immune tolerance.
It has been suggested that the so-called electron-ion interaction potential (EIIP) plot of peptide sequences, and its Fourier transform (informational spectrum method, ISM) may be a good general predictor of peptide-ligand interactions (15) . The present work was undertaken in order to test the hypothesis that peptide analogs that have a predetermined immunological profile, but bearing little or no sequence similarity with the native peptide antigen, can be designed by ISM. We demonstrated that two peptides with different primary sequences but closely related information spectra may possess similar immune reactivity, while peptides with very similar primary sequences but different information spectra can have quite different immune profiles. Based on these results, we defined the bioinformatics criterion for design of gp120/VIP peptide mimetics for prevention and therapy of HIV disease.
Materials and Methods

Bioinformatic analysis of peptides
Distribution of periodical patterns and tandem repeats of residues in protein and DNA sequences determine structural and functional characteristics of the molecules. The ISM is a virtual spectroscopy technique, which allows investigation of the periodicity of structural motifs with defined physicochemical characteristics, which determine biological properties of protein and DNA sequences. Physical and mathematical basis of ISM is described in detail elsewhere (15) (16) (17) (18) ; here we will only briefly present this bioinformatic method. A sequence of N residues is represented as a linear array of N terms, with each term given a weight. The weight assigned to a residue is EIIP (19, 20) , determining electronic properties of amino acids and nucleotides, which are responsible for their intermolecular interactions (21, 22) . In this way, the alphabetic code is transformed into a sequence of numbers. The obtained numerical sequence, representing the primary structure of protein, is then subjected to a discrete Fourier transformation, which is defined as follows:
where x(m) is the mth member of a given numerical series, N is the total number of points in this series, and X(n) are discrete Fourier transformation coefficients. These coefficients describe the amplitude, phase and frequency of sinusoids, which comprised the original signal. The absolute value of complex discrete Fourier transformation defines the amplitude spectrum and the phase spectrum.
The complete information about the original sequence is contained in both spectral functions. However, in the case of protein analysis, relevant information is presented in an energy density spectrum (15, 16) , which is defined as follows:
In this way, sequences are analyzed as discrete signals. It is assumed that their points are equidistant with the distance The ISM has been successfully applied in structure-function analyses of different protein sequences, as well as in de novo design of biologically active peptides (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) .
Multiple alignment and dendograms
The multiple alignment of the sequences was carried out with the CLUSTALW program (37) . The dendrograms of the immunological profiles and information spectra were based on a simple Eucledian distance of the form
2 where x i and y i are the immunoreactivity data against serum i (or the spectrum amplitude at frequency i) for peptide x and y, respectively. The dendrograms were drawn by the program PHYLIP using the nearest neighbor method (38) .
Human subjects and their sera
Serum samples were collected from 46 HIV-positive subjects (CD4 count, 50-600/lL). Samples from 10 healthy HIV-negative subjects were randomly selected from individuals referred to the blood donor service. 
VIP (1-28) (HSDAVFTDNYTRLRKQMAVKKYLNSILN) was
purchased from Sigma Chemical. All peptides except V3
were coupled to bovine serum albumin (BSA) with
, while V3 peptide was crosslinked to BSA with glutaraldehyde.
ELISA assay
Polystyrene microtiter plates (Greiner, Germany) were incubated overnight at 4°C with 100 lL of BSA-coupled peptides (1 lg/well) diluted in carbonate buffer, pH 9.6.
Plates were washed with phosphate-buffered saline (PBS)-0.05% Tween and non-specific sites were blocked with 200 lL PBS containing 1% BSA for 1 h at room temperature. After further washing, serum specimens were then added to the wells (100 lL/well). Sera were diluted in 0.1%
BSA in PBS. Plates were incubated for 1 h at room temperature. After three washings with PBS-0.05% Tween, 100 lL of goat anti-human IgG peroxidase-conjugated anti- Figure 1 . Peptides used in this study. The multiple alignments were produced with the CLUSTALW program (37) using gap open and gap extension penalties of 10 and 0.05, respectively. Black shading denotes >50% identity while gray shading denotes >50% similarity.
bodies (Sigma), diluted 1 : 5000 was added and the plates were incubated for 1 h. After five washings, the 2,2¢-azinobis(3-ethylbenzothiazoline-6-sulfonate) (ABTS) substrate was added and the absorbance measured at 405 nm.
Affinity purification of antibodies
One milliliter of HIV + serum from a single donor (diluted with TBS, 2.5 mL TBS/mL gel) was chromatographed on an affinity column consisting of VIP-BSA coupled to CNBr-activated Sepharose 4B (2 mg peptide/5 mL of resin).
After the samples had been loaded, the gel was washed with five column volumes of PBS. Washing was continued with 
Results
The peptide sequences and their IS are shown in Figs 1 and   2 , respectively. We used the peptide NTM, derived from the C2 region of the HIV-1 gp120 (13) as a native model antigen.
Peptide NTMM was designed as an analog having 91%
sequence identity with NTM but significantly different informational spectrum. It is important to note that peptides NTM and NTMM share a common sequence FTDN representing an exposed B-cell epitope (9). Previously we showed that VIP and NTM, despite significantly different primary structures, have very similar IS (13) . It has been also shown that NTM and VIP are immunologically crossreactive (14) . For this reason VIP was used as a natural Figure 3 . Comparison of the sequence-, immunological and information-spectrum similarities. Unrooted trees were produced with the PHYLIP program (38) as described in the text. The shaded area indicates that peptides NTM, VIP, and p 32 are closely related in terms of both immunological properties and information spectra. The C2 region of gp120 including its C-terminus adjacent to V3 loop Table 1) . Linear correlation coefficients were calculated between the data for each peptide ( Table 1) . A strong immunological crossreactivity was found between NTM and VIP (r ¼ 0.87), which is in good agreement with our previous results on HIV-negative sera (2) . On the other hand, crossreactivity between NTM and NTMM (r ¼ 0.19),
as well as the control peptide V3 (r ¼ )0.38) is very weak.
Peptide p 32 is highly crossreactive with NTM (r ¼ 0.75), even though it has much less sequence similarity to it than does NTMM (56 vs. 91%).
The comparison of these peptides has been graphically summarized in the form of unrooted trees (Fig. 3) . In this Tables 2 and 3) .
It has been previously demonstrated that antibodies in sera of HIV-infected patients reacting with the C-terminus of the C2 region strongly correlate with disease progression (1). These results indicate that the C2-derived peptides may be promising antigens for the development of a preventive and therapeutic AIDS vaccine, as well as potential AIDS therapeutics (2). We have proposed, based on the ISM analysis of this gp120 region, that antibodies from HIV-positive sera that bind peptide NTM, may, in fact, represent natural anti-VIP autoantibodies (13, 14) . Recently, we also showed a significant therapeutic potential of these antibodies (2).
Here we demonstrate that information encoded by pri- 
